Equities

KORU Medical Systems Inc

KRMD:NAQ

KORU Medical Systems Inc

Actions
  • Price (USD)2.57
  • Today's Change-0.10 / -3.75%
  • Shares traded36.47k
  • 1 Year change-9.19%
  • Beta0.4127
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments111725
Total Receivables, Net4.074.534.31
Total Inventory3.486.406.11
Prepaid expenses1.221.461.57
Other current assets, total------
Total current assets203037
Property, plant & equipment, net7.357.671.20
Goodwill, net------
Intangibles, net0.750.790.81
Long term investments------
Note receivable - long term------
Other long term assets0.100.100.02
Total assets284241
LIABILITIES
Accounts payable0.982.391.23
Accrued expenses2.543.782.97
Notes payable/short-term debt0.310.430.51
Current portion long-term debt/capital leases0.110.100
Other current liabilities, total0.510.260.09
Total current liabilities4.456.964.79
Total long term debt0.320.390
Total debt0.740.930.51
Deferred income tax------
Minority interest------
Other liabilities, total3.343.650
Total liabilities8.11114.79
SHAREHOLDERS EQUITY
Common stock0.490.490.48
Additional paid-in capital474441
Retained earnings (accumulated deficit)(23)(9.57)(0.91)
Treasury stock - common(3.84)(3.84)(3.84)
Unrealized gain (loss)------
Other equity, total------
Total equity203137
Total liabilities & shareholders' equity284241
Total common shares outstanding464545
Treasury shares - common primary issue3.423.423.42
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.